一个保存的Magnaporthe oryzae效应器通过破坏E2功能来抑制免疫力来对抗大米的乌比基-蛋白酶系统
Min Wang1,2, Ruyi Wang1, Yehui Xiong3
1State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.
Plant biotechnology journal
|March 16, 2026
概括
病原体作用者可以通过破坏无素-蛋白酶系统 (UPS) 来逃避植物免疫力. 这项研究表明,米病原体效应因子抑制宿主E2酶,揭示了一种新的免疫逃避策略.
科学领域:
- 植物病原体相互作用
- 分子植物病理学
- 乌比奎丁-蛋白酶体系统
背景情况:
- 病原体分泌效应因子入侵宿主,通常针对宿主的无素-蛋白酶系统 (UPS).
- 病原体效应剂通常会破坏E3酶的功能,但对E2无素结合酶的干扰却不太了解.
- 大米爆发真菌Magnaporthe oryzae导致了大量的作物损失.
研究的目的:
- 为了调查病原体效应因子是否干扰E2无素结合酶.
- 阐明M. oryzae效应器MoCE1与大米UPS组件之间的相互作用机制.
- 了解MoCE1如何促进M. oryzae的致病性.
主要方法:
- 鉴定和特征的M. oryzae效应器MoCE1.1.
- 对MoCE1与大米E3结合酶OsRING10和E2酶OsUBC11的相互作用进行分析.
- 研究MoCE1对OsUBC11酶活性和植物免疫的影响.
主要成果:
- MoCE1对于M. oryzae的致病性至关重要,并被分泌到米细胞中.
- 米E3结合酶OsRING10和E2酶OsUBC11通过K48结合的多基化来协同降解MoCE1.
- 过度表达OsRING10或OsUBC11可增强大米对M. oryzae的耐药性.
- MoCE1抑制了OsUBC11的酶活性,以抵消宿主防御.
结论:
- 病原体效应器MoCE1是主机E2-E3UPS机械的降解目标.
- MoCE1采用一种新的策略来抑制E2酶活性,从而逃脱UPS介导的免疫力.
- 这项研究揭示了病原体效应因子和宿主UPS组件之间的复杂相互作用,用于毒性和防御.
关键词:
马格纳波特花 (Magnaporthe oryzae) 是一个很大的植物.效应器效应器是一个有效的效应器.植物免疫力 植物免疫力米米饭 米饭 米饭 米饭.乌比奎胺结合酶的结合酶无处不在的合酶乌比奎丁-蛋白酶体系统更多相关视频
相关概念视频
Experimental RNAi
8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
The Unfolded Protein Response
6.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.7K
Regulation of the Unfolded Protein Response
3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Stringent Response in E. coli
454
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
454
Riboswitches
10.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
10.0K
RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K


